Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you're looking into weight loss injections in Bristol, the most important thing to know upfront is this: the two licensed options in the UK, Mounjaro (tirzepatide) and Wegovy (semaglutide), are prescription-only medicines. A qualified prescriber must assess your health before any treatment begins. Bristol residents can access a same-day clinical review through a GPhC-registered online pharmacy without leaving home, with next-working-day delivery to any Bristol address. These medicines are not quick fixes, and they are not suited to everyone, but for adults who meet clinical criteria they represent the most evidence-backed pharmacological weight management options currently available in the UK, as detailed in NICE technology appraisal TA1026.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The single biggest misconception about weight loss injections is that the medicine handles everything. It does not. Mounjaro and Wegovy reduce appetite significantly and alter the hormonal signals that drive hunger, but the trial results that made headlines (around 20–21% average body weight reduction with tirzepatide at 15mg over 72 weeks in SURMOUNT-1, published in the New England Journal of Medicine) were achieved by participants who also followed a reduced-calorie diet and increased their physical activity. The medicine creates a window; what you do inside that window shapes your results.
This matters practically. People who start treatment expecting transformation without any lifestyle change often find the experience harder and the results thinner than they hoped. Those who use the reduced appetite as an opportunity to build better habits tend to do considerably better. Our prescribers at nume make this clear at the consultation stage, not to gatekeep, but because honest framing produces better outcomes.
A related myth: that a higher dose is always better. Treatment starts at a low tolerability dose and increases only under clinical oversight. Jumping straight to a higher dose is not how the licensed schedule works, and it is not something any legitimate prescriber would do.
Two medicines are licensed in the UK for weight management. Mounjaro is a dual GIP and GLP-1 receptor agonist, the only medicine of its kind currently available for weight loss in the UK. Wegovy is a GLP-1 receptor agonist, with a well-established evidence base going back several years. If you want to understand how each option compares side by side, our guide to the 3 weight loss injections currently available in the UK sets out the differences clearly. A third option, the Wegovy tablet (oral semaglutide), received MHRA approval in June 2026 as the first licensed oral GLP-1 medicine for weight management in the UK.
Ozempic, which contains the same active ingredient as Wegovy but at different doses, is licensed for type 2 diabetes only. Saxenda (liraglutide) is a separate GLP-1 medicine that is licensed for weight management but is not dispensed by nume. Our overview of weight loss injections covers how each medicine fits into the licensed landscape if you want a broader comparison before your consultation.
Bristol residents often ask whether their GP can prescribe these medicines. Increasingly yes, from April 2026, participating GP practices can prescribe tirzepatide under the updated GP contract for patients who meet NHS eligibility criteria, though criteria remain strict and availability varies by practice. Many people who do not meet NHS thresholds, or who prefer not to wait, choose a regulated private route instead.
Gastrointestinal effects are the most frequently reported: nausea, vomiting, loose stools, constipation and indigestion. They tend to peak after a new dose is introduced and settle within a week or two for most people. Fatigue and headaches appear in the first weeks too. Keeping yourself well hydrated matters, GI side effects are less disruptive on a good fluid intake.
A practical note many people find useful: storing the pen in the fridge door and injecting at the same time each week builds a routine that reduces the chance of a missed or delayed dose. If you are still weighing up whether a weight loss injection is the right approach for your situation, the Patient Information Leaflet covers exactly what to do if a dose is delayed.
In January 2026 the MHRA issued guidance highlighting acute pancreatitis as an infrequent but serious risk with GLP-1 medicines. Severe stomach pain that extends towards the back, with or without vomiting, needs urgent medical attention. Report any unexpected effects through the MHRA's Yellow Card scheme. These medicines are not recommended during pregnancy, while breastfeeding, or for anyone trying to conceive. They are not licensed for under-18s.
The only legal route to these medicines is a prescription following proper clinical assessment. For context on what a legitimate private service includes, our weight loss injections guide for Coventry and the Brighton equivalent both cover what the process looks like from an unverified seller versus a GPhC-registered pharmacy, the same principles apply in Bristol. Any seller offering these medicines without a clinical consultation is not operating legally, and in some cases the products themselves are counterfeit. The MHRA has seized large quantities of fake pens over the past two years, some containing substances that caused hospitalisations.
To check whether an online pharmacy is properly registered, use the GPhC register. It takes thirty seconds and is the clearest signal that a service is operating within UK law. Discount codes and below-market prices for prescription medicines are a red flag, not a deal. For a broader view of what to look for in a credible service, our guide to pricing and what it should include walks through the questions worth asking.
When you are ready to explore whether treatment is right for you, speak to our prescribers through a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber, not software.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.